SYDNEY — The S&P/ASX 200 fell 24.4 points, or 0.27%, to 9,045.6 as of 3:22 p.m. AEST Wednesday, as sliding gold prices and surging global bond yields weighed on the market a day after biotechnology giant CSL delivered one of the strongest single-session rallies of the current earnings season.

Wednesday’s decline followed a steadier session Tuesday, when the index closed nearly flat at 9,070 points, halting a four-day losing streak that had pushed the benchmark to a two-week low. According to Trading Economics, bargain hunters stepped into the market Tuesday as August consumer confidence data improved, with mortgage holders reporting less anxiety about the prospect of further interest rate hikes.

CSL was the standout performer of Tuesday’s session, surging 17.25% after the biopharmaceutical company’s underlying profit exceeded analyst forecasts and management signaled a return to growth following what had been described as a difficult reset year for the business. Following the result, brokerage Bell Potter retained its hold rating on CSL shares while lifting its price target significantly, to $150.00 from $120.00. “Based on the new underlying NPAT metric, CSL trades on a PE multiple of ~19x FY26 and ~18x FY27 earnings, with flat revenue growth and low-to-mid single digit earnings growth expected for FY27,” Bell Potter said in a note. “While the result today suggests the worst (by way of earnings declines) is in the rear-view for CSL, we find it difficult to justify a greater premium than is now being attributed relative to global biopharma peers.”

Mining giant BHP also posted strong gains Tuesday, rising 2.65% after reporting that its underlying annual profit had increased 30% to $13.20 billion. Operating earnings from the company’s copper division reached $18.19 billion, surpassing the $14.53 billion generated by its traditional iron ore business, underscoring the increasing importance of copper to BHP’s overall earnings mix. Argo Investments portfolio manager Andy Forster offered a succinct assessment of the result. “Solid overall, and copper doing all the work,” Forster said, reflecting broader market commentary that gains in copper and healthcare had lifted the overall index Tuesday even as interest-rate-sensitive sectors, including the major banks, lagged behind.

Banks acted as the primary drag on Tuesday’s session, with the sector continuing to face pressure from concerns over the interest rate outlook. National Australia Bank slumped 4.7% amid investor concerns that a proposed repeal of property-investment tax breaks could weigh on the bank’s future earnings and credit growth, according to Trading Economics.

Wednesday’s pullback has been driven in significant part by a sharp fall in gold prices overnight. According to CNBC, gold futures fell 1.8% to $4,394 an ounce as traders sold off the precious metal following a surge in global bond yields to their highest levels in decades. That decline is expected to weigh heavily on ASX-listed gold miners, including Westgold Resources and Northern Star Resources, both of which were flagged as likely to face a difficult session Wednesday given their direct exposure to the falling gold price.

Wednesday’s session also carries added significance given the scheduled release of Australia’s Wage Price Index at 11:30 a.m. AEST. The previous quarter’s wage growth figure came in at 0.8%, with annual wage growth running at 3.3%. Economists and investors are watching the release closely given its potential to shift interest rate expectations across several rate-sensitive sectors, including banking, property and retail.

A busy slate of corporate earnings continued to roll out Wednesday, with Santos, Evolution Mining, Temple & Webster, Breville, Mirvac and Whitehaven Coal all scheduled to release results during the session. Among the more notable individual results, one electrical and communications contractor delivered record profitability despite a 10.3% decline in revenue to $718.7 million, as project completions tied to the CBESS and Western Sydney International Airport Terminal developments wound down during the first half. Gross profit for that company rose 29.1% to a record $136.7 million, with gross margin expanding significantly to 19.0% from 13.2% a year earlier. Underlying net profit after tax rose 24.3% to $39.4 million, though statutory net profit fell 77.6% to $7.1 million due to $46.1 million in costs tied to a dispute over the WestConnex toll road project. The company lifted its total fully franked dividend by 33.3% to 10.0 cents per share, including a record final dividend of 7.5 cents, while maintaining a record cash balance of $261.5 million and no outstanding debt.

Separately, a finance and insurance-focused company reported its loan book had grown a further 7.5% since March, with arrears holding up well, while reiterating a medium-term target of $100 million in net profit before tax by fiscal 2031 as it continues expanding its auto retail branch network.

Wednesday’s session also featured a notable ex-dividend adjustment affecting the broader index, with shares tied to a $2.70 fully franked dividend beginning trading ex-dividend at the ASX’s opening phase at 9:59:45 a.m. AEST, a technical adjustment that tends to exert modest automatic downward pressure on the headline index independent of broader market sentiment.

Looking at the broader context, the ASX 200 remains well below the all-time high of 9,198.6 points it reached in February, having settled closer to the 8,800 level by July before recovering ground through the current August earnings season. With reporting season continuing through the remainder of the week alongside Wednesday’s wage data release, investors are likely to remain focused on how individual corporate results, particularly from the mining, energy and consumer sectors still due to report, continue to shape the index’s trajectory against a backdrop of volatile gold prices and rising global bond yields.

Mumbai: Indian markets remained under pressure on Tuesday, with the Nifty ending lower for the sixth straight trading session, as the rebound in oil prices amid the lingering West Asia conflict and persistent volatility around the Closing Auction Session (CAS) kept traders on the toes.

NSE’s Nifty fell 132.75 points, or 0.55%, to close at 24,154.9. The BSE Sensex declined 492.7 points, or 0.6%, to end at 77,235.46.

“Markets remained under pressure as there have been no positive cues from the US-Iran talks, especially with the MOU having expired and crude oil prices moving higher,” said Shrikant Chouhan, head of equity research at Kotak Securities.

Brent crude October futures were trading near the $91-a-barrel mark on Tuesday and have remained in the $85-$90 range over the past week. Chouhan said oil sustaining above the $85 mark is a key concern, as it raises inflationary risks, which is already reflected in the sharp rise in US 10-year and 30-year bond yields. “We believe this could lead to outflows from both emerging and developed equity markets,” he said.

The price adjustments on account of the CAS resulted in the benchmark indices dropping nearly 0.2% in the last 15 minutes before trade close.

Chouhan said the volatility seen during the CAS session is largely due to lower participation.
On Tuesday, FPIs net bought shares worth ₹1,651.5 crore. Domestic institutional investors were buyers to the tune of ₹2,579 crore. The Nifty Midcap 150 fell 0.4%, while the Nifty Smallcap 250 rose 0.2%. Of the total 4,530 stocks on the BSE, 1,890 advanced and 2,426 declined.
In Asia, Japan fell 2.5%, South Korea declined 1.55%, Taiwan dropped 1.2%, while China advanced 0.2% and Hong Kong rose 0.1%. The STOXX 600 index was down 0.5% at the time of going to press.

Read more: Regulatory tailwinds to boost growth for MCX, says HDFC Securities, retains Buy for 18% gains

Technical indicators suggest the indices could move in a band in the near term. “The market’s sentiment has shifted, with the index now consolidating within the 24,000-24,500 range, and this phase of consolidation could continue over the next few trading sessions,” said Dharmesh Shah, head of technical research at ICICI Securities.

Shah said after 1,100-point rally, the Nifty is undergoing a retracement and may find support in the 23,900-24,000 zone before resuming its upward trajectory towards the upper end of the channel at 24,500-24,600. “While Q1 earnings was better than expected, a decline in crude oil prices, a reversal in US 10-year bond yields, or a de-escalation of tensions in West Asia could act as positive catalysts and trigger the market’s next rally,” said Shah.

Yes. Corporate subscriptions are available for teams and organisations, with discounted rates as user numbers increase. Pricing starts from $1,625 + GST per user.
Get in touch
to discuss the right option for your organisation.

Business News subscriptions are used by executives, investors, consultants and professionals who need to stay informed and make better decisions about the WA market. When you subscribe you’ll get

• Unlimited access to WA’s most trusted business journalism
• Data & Insights — detailed profiles of WA companies, people, projects and deals
• MyBN — a personalised feed based on the companies, people and sectors you follow
• Special publications and industry reports
• Daily and weekly email newsletters

Data & Insights is a research tool built specifically for the WA market. It draws on more than 30 years of Business News reporting, updated regularly to reflect what’s happening now. Use it to:

• Look up detailed profiles of WA companies, including financials, directors and ownership
• Find decision-makers and track their career movements
• Research live and completed projects across WA industries
• Monitor deals, appointments and market activity
• Access industry rankings and league tables

Data & Insights is updated daily by our dedicated research team, which uses the latest announcements, ASX filings and editorial coverage to keep our person, company, list and project records up to date.

Business News welcome all opportunities to make our dataset accurate, complete and current, so if you have an update request, please email the team at
general@businessnews.com.au, and we’d be happy to assist.

MyBN
is part of every subscription. It’s your personalised view of Business News. You can follow the companies, people, sectors and projects that matter to you, and get a news feed and alerts tailored to your interests. You can save articles to read later and retain only what you need.

Only subscribers have full access to all content on the Business News website.

If staying informed about the WA economy is part of your job, and/or you’re looking for networking opportunities in WA, Business News is built for you.

Business News subscribers are:

• Executives and directors tracking competitors, clients and market movements
• Investors and advisers researching companies, deals and industry trends
• Consultants and professionals staying across sectors relevant to their clients
• Business owners looking for leads, context and market intelligence

Most Business News publications cover national or global markets. Business News is focused entirely on Western Australia, which means the journalism, the data and the intelligence are all built around WA companies, people and projects — not adapted from a national feed. Data & Insights, included with every subscription, combines more than 30 years of WA-specific editorial research with live business data. There’s no comparable product for the WA market.

The Morning Digest Email provides a comprehensive wrap of the major headlines, relevant to WA business, and includes with a snapshot of the overnight news covering oil, gold and ASX-listed companies.

The Afternoon Wrap Email focuses on the news covered by our team of journalists during the course of the working day, including exclusive stories and analysis, all of which relates to WA business and the local economy.

The BN Weekender Email contains a wrap of the Business News from the week that was, highlighting the top stories in each area of WA business.
Sign up for free.

We’re happy to help.
Get in touch
and our team will come back to you.

Apple’s decision to put iPhones, iPads and Macs on a formal leasing model in the United States looks at first like a consumer-finance story.

For UK SMEs, it raises a much more interesting question: when smartphones are essential work tools that depreciate quickly, is outright ownership still the best way to buy them?

As Business Matters reported when Apple Upgrade launched, Apple has partnered with Klarna to offer 12- and 24-month leases on iPhones and Apple Watches, with longer terms on Macs and iPads. Customers can return the hardware, buy it outright or enter a new lease at the end of the term. The scheme is US-only for now, but the structure is a useful preview of where business-device procurement may be heading.

Why leasing looks attractive to smaller businesses

The obvious appeal is cash flow. Buying 20 premium smartphones in one month creates a visible capital hit; spreading the cost over a predictable term makes budgeting easier and keeps cash available for payroll, marketing or growth. It also aligns the device payment with the period during which staff actually use the hardware.

Klarna’s official announcement says Apple Upgrade lets users trade in an existing device at the start to reduce the monthly cost, then choose whether to return, buy or upgrade at the end. That model removes some of the friction around keeping a fleet current.

But ownership has something leasing hides: residual value

A company-owned phone is not just an expense. Until it is written off, lost or left in a cupboard, it is also a resaleable asset. That matters because recent flagship phones can retain hundreds of pounds of value long after they have been replaced operationally.

For illustration, SellMyPhone’s iPhone 16 Pro comparison showed a leading offer of about £511 for a working device when checked in August 2026. Twenty similar handsets would therefore represent more than £10,000 of gross resale value before any bulk pricing, condition adjustments or business-specific terms are considered. The exact number changes daily, but the principle is important: a fleet has an exit value.

Businesses that own their hardware can recover that value through a structured business phone recycling process rather than simply returning every device to a lessor. That residual value belongs in the total-cost calculation from day one.

Lease versus buy: the total-cost question

The wrong comparison is monthly lease payment versus purchase price. The useful comparison is the total cost of providing a working phone to an employee for two or three years after financing, insurance, repairs, administration and residual value are all included.

Factor	Own the fleet	Lease the fleet
Upfront cash	Higher	Lower
Monthly predictability	Medium	High
Hardware control	High	Subject to lease terms
Residual value	Retained by business	Usually surrendered unless bought out
Upgrade administration	Managed internally	Can be simpler
End-of-life process	Business must manage securely	Return process may be built in
Flexibility to keep devices longer	High	Depends on agreement

For a five-person creative agency, the administrative simplicity of leasing may be worth paying for. For a 200-device field workforce that already has IT asset-management processes, retaining the residual value could materially change the economics. There is no universal answer.

The hidden cost is poor lifecycle management

The biggest mistake is not necessarily choosing the wrong finance model. It is buying phones, replacing them every two or three years, and then failing to close the loop. A £500 device that sits unused for 12 months is not a £500 asset any more. It is a depreciating asset that no employee is using.

That is why SMEs should treat mobile hardware like any other managed business asset. Record the model, storage, condition, assigned employee, purchase date and planned replacement date. When a device leaves service, wipe it securely, obtain a market valuation and make a deliberate decision to redeploy, sell or recycle it.

A leasing trend could change how firms think about phones

Apple Upgrade does not yet give UK SMEs a new procurement option, and it would be premature to assume the US model will be copied here unchanged. What it does do is challenge an old assumption: that buying the handset is automatically the normal way to provide mobile technology.

As subscription and device-as-a-service models spread, finance directors should ask a more disciplined question. Do we want the lowest upfront cost, the simplest replacement cycle, or the best whole-life return from the asset?

Three questions to ask before the next fleet refresh

• What is the true two- or three-year cost per employee after resale value is deducted?
• Who owns the residual value at the end of the agreement?
• Does the business have a reliable process for wiping, collecting and selling redundant devices quickly?

For firms that buy outright, the final question is especially important. A company can use SellMyPhone’s business comparison service to put multiple devices in front of UK recyclers, obtain competing quotes and arrange certified data erasure rather than treating end-of-life hardware as an afterthought.

Apple’s leasing experiment may or may not become the dominant model. But it has made one thing clearer: smartphones are now significant business assets with a financing cost, an operational life and an exit value. SMEs that measure all three will make better procurement decisions than those that focus only on the monthly bill.

Gold prices edged higher in early Asian trade on Wednesday as U.S. Treasury yields eased from recent highs, while market participants awaited the release of the Federal Reserve’s meeting minutes.

FUNDAMENTALS

Spot gold was up 0.2% at $4,342.33 per ounce, as of 0030 GMT after falling nearly 2% on Tuesday. Meanwhile, U.S. gold futures for December delivery ‌edged 0.6% ⁠lower to $4,396.30.
⁠U.S. yields backed off earlier highs, switching directions amid a global bond selloff that saw ​long-term borrowing costs in major economies edge toward their highest levels in decades. [US/]

U.S. ​President Donald Trump said no talks were taking place with Iran and insisted the Strait of Hormuz was open, contradicting Iran’s assertion that the critical ​waterway remained shut to shipping. The receding prospects ⁠of a ‌deal to end the nearly six-month conflict drove up oil ​prices. [O/R]

Rising ​energy prices could bolster the case for higher interest ⁠rates to rein in inflation, despite recent U.S. economic indicators ​showing unexpected employment losses, milder inflation, and weak July ​retail spending.

Despite gold being known as an inflation hedge, higher rates usually weigh on gold prices as they strengthen the dollar and make yield-bearing assets more attractive to investors.
The Fed’s release of minutes from the most recent meeting of its monetary policy-setting Federal Open Market Committee is ‌due at 1800 GMT.Traders are currently pricing in a 65% probability that the U.S. central bank will keep rates ​unchanged and a ​35% chance of ⁠a rate hike in September, according to the CME FedWatch Tool.

Meanwhile, the Bank of England will leave interest rates unchanged at 3.75% for the rest of the year, according to a strong majority of economists polled by Reuters.

Among other metals, spot silver fell 0.5% to $62.99 per ounce. Platinum climbed 0.3% to $1,717.03, while palladium lost 0.3% at $1,286.73.

DATA/EVENTS (GMT)

0600 UK Core CPI YY Jul

0600 UK CPI YY Jul

0600 UK CPI Services MM, YY Jul

0600 EU HICP Final MM, YY Jul

The biopharmaceutical and biotechnology company Symbiotec Pharmalab is set to tap the capital markets with an initial public offering (IPO) worth Rs 1,757 crore. The company has fixed the price band at Rs 938–Rs 988 per share, with the issue opening for subscription on August 24, 2026, and closing on August 27, 2026.

Investors can bid for a minimum of 15 equity shares, with bids thereafter available in multiples of 15 shares. At the upper end of the price band, the minimum investment will be Rs 14,820.

The IPO is proposed to be listed on both the BSE and NSE, with the tentative listing date scheduled for September 1, 2026. The allotment is likely to be finalised on August 28, 2026.

The company is offering eligible employees a Rs 90-per-share discount on bids made through the employee reservation portion.

Valuation Under the Spotlight

Symbiotec Pharmalab’s IPO valuation is likely to attract close attention from investors. Based on diluted earnings per share for fiscal 2026, the price-to-earnings (P/E) ratio stands at 49.37 times at the lower end of the price band and rises to 52.00 times at the upper end.

The company’s weighted average return on net worth for the last three financial years was 10.99%.
With the IPO price band translating to 469 times the face value at the floor price and 494 times at the cap price, the issue is positioned as a premium offering in the pharmaceutical and biotechnology space.

Where Will the IPO Proceeds Go?

The primary objective of the issue is to strengthen the company’s balance sheet. Symbiotec Pharmalab plans to use the proceeds for prepayment and/or repayment, either fully or partially, of certain outstanding borrowings. The remaining funds will be utilised for general corporate purposes.

Symbiotec Pharmalab

Founded in 2002, Symbiotec Pharmalab operates across the biopharmaceutical and biotechnology space, developing and manufacturing active pharmaceutical ingredients (APIs), nutritional ingredients and specialised products for domestic and international markets.

The company’s journey began with laboratory-scale manufacturing of steroidal-hormone APIs in 1995. Over the years, it has expanded into an industrial-scale, backward-integrated manufacturing platform serving the pharmaceutical, nutraceutical and wellness sectors.

Research-driven manufacturing, quality and sustainability form key elements of its business strategy. Its manufacturing operations have also secured approvals and certifications from several international regulatory bodies, including the US FDA, EU-GMP authorities and South Korea’s Ministry of Food and Drug Safety.

As of June 30, 2025, Symbiotec Pharmalab operated two industrial-scale API manufacturing plants. Together, these facilities had a maximum capacity of 584.67 metric tonnes (MT) for chemical synthesis and 300 kilolitres of fermentation capacity.

The combination of backward integration, specialised API capabilities and international regulatory approvals gives the company an established position in a segment where manufacturing quality and regulatory compliance can be critical differentiators.

IPO Management Team

The IPO is being managed by JM Financial, Avendus Capital, Motilal Oswal Investment Advisors and Nomura Financial. MUFG Intime India Pvt. Ltd. is acting as the registrar to the issue.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)